| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| F Blandini, S A Joseph, C Tassorell. Systemic administration of ephedrine induces Fos protein expression in caudate putamen and subthalamic nucleus of rats. Functional neurology. vol 12. issue 5. 1998-02-26. PMID:9439947. |
this may be related to dopaminergic agonist properties that have been attributed to this compound, dopamine receptors being present in both cpu and stn. |
1998-02-26 |
2023-08-12 |
rat |
| D E Schmidt, M H Ebert, J C Lynn, W O Whetsel. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures. Journal of neural transmission (Vienna, Austria : 1996). vol 104. issue 8-9. 1998-02-26. PMID:9451719. |
this study was undertaken to evaluate the neuroprotective effects of deprenyl in mpp(+)-treated cultures by measuring changes in the levels of hva as an indicator of dopamine release and metabolism by dopaminergic neurons and to correlate this indication of dopaminergic function with morphological evidence of survival or loss of dopaminergic neurons in mature csn cultures. |
1998-02-26 |
2023-08-12 |
Not clear |
| T Umezu, J Yonemoto, Y Soma, T Suzuk. Tris(2-chloroethyl)phosphate increases ambulatory activity in mice: pharmacological analyses of its neurochemical mechanism. Toxicology and applied pharmacology. vol 148. issue 1. 1998-02-24. PMID:9465270. |
mus and bac did, but dz did not, inhibit the aa increasing effect of the dopaminergic agonist apomorphine (apo), suggesting that dopamine is involved in the control of aa, and that gaba can affect aa through interaction with dopaminergic neurons. |
1998-02-24 |
2023-08-12 |
mouse |
| P M Kunko, R J Loeloff, S Izenwasse. Chronic administration of the selective dopamine uptake inhibitor GBR 12,909, but not cocaine, produces marked decreases in dopamine transporter density. Naunyn-Schmiedeberg's archives of pharmacology. vol 356. issue 5. 1998-02-19. PMID:9402035. |
in order to examine more closely the dopaminergic contribution to this effect, the selective dopamine uptake inhibitor gbr 12,909 (30 mg/kg/day), cocaine (50 mg/kg/day), or vehicle, were continuously infused via osmotic minipump, and their effects on the dopamine transporter examined. |
1998-02-19 |
2023-08-12 |
rat |
| A Haapalinna, T Viitamaa, E MacDonald, J M Savola, L Tuomisto, R Virtanen, E Heinone. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Naunyn-Schmiedeberg's archives of pharmacology. vol 356. issue 5. 1998-02-19. PMID:9402036. |
atipamezole increased dopaminergic activity only slightly, whereas yohimbine elevated central dopamine but decreased central 5-hydroxytryptamine turnover rates. |
1998-02-19 |
2023-08-12 |
mouse |
| B Floran, L Floran, A Sierra, J Aceve. D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neuroscience letters. vol 237. issue 1. 1998-02-13. PMID:9406865. |
attempting to better understand the role of the dopaminergic innervation in the rat globus pallidus, we examined here whether or not endogenous dopamine modulates the release of [3h]gaba in superfused pallidal slices. |
1998-02-13 |
2023-08-12 |
rat |
| L Williams-Hemby, L J Porrin. II. Functional consequences of intragastrically administered ethanol in rats as measured by the 2-[14C]deoxyglucose method: the contribution of dopamine. Alcoholism, clinical and experimental research. vol 21. issue 9. 1998-02-13. PMID:9438516. |
in this study, a dopaminergic antagonist, flupenthixol, was used to determine the contribution of dopamine to the ethanol-induced increases in functional activity. |
1998-02-13 |
2023-08-12 |
rat |
| L R Faro, R Durán, J L do Nascimento, M Alfonso, C W Picanço-Dini. Effects of methyl mercury on the in vivo release of dopamine and its acidic metabolites DOPAC and HVA from striatum of rats. Ecotoxicology and environmental safety. vol 38. issue 2. 1998-02-06. PMID:9417850. |
in the present work, the effects of chronic doses of methyl mercury (mehg) were studied on the dopaminergic system of the rat striatum, using microdialysis coupled to high-performance liquid chromatography in order to quantify the in vivo release of dopamine (da) and its acidic metabolites dopac and hva. |
1998-02-06 |
2023-08-12 |
rat |
| J O Rinne, N Sahlberg, H Ruottinen, K Någren, P Lehikoine. Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography. Neurology. vol 50. issue 1. 1998-02-06. PMID:9443472. |
we conclude that the brain dopaminergic system is affected in ad because the striatal uptake of the dopamine reuptake ligand [11c]beta-cft is decreased. |
1998-02-06 |
2023-08-12 |
human |
| S Striem, A Bar-Joseph, Y Berkovitch, A Biego. Interaction of dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system. European journal of pharmacology. vol 338. issue 3. 1998-02-05. PMID:9424014. |
overall, the results of the present study demonstrate that hu-211 interacts with the dopaminergic system and enhances activity at the dopamine d1 receptor level. |
1998-02-05 |
2023-08-12 |
Not clear |
| I Izquierdo, J H Medin. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiology of learning and memory. vol 68. issue 3. 1998-02-04. PMID:9398590. |
the late modulation relies on dopamine d1, beta-noradrenergic, and 5ht1a receptors in the hippocampus and dopaminergic, noradrenergic, and serotoninergic pathways. |
1998-02-04 |
2023-08-12 |
rat |
| T Müller, W Kuhn, T Büttner, H Przunte. Distorted colour discrimination in Parkinson's disease is related to severity of the disease. Acta neurologica Scandinavica. vol 96. issue 5. 1998-02-04. PMID:9404998. |
but it remains unclear whether these alterations of colour vision reflect striatal dopamine deficiency or changes of retinal dopaminergic pathways in pp. |
1998-02-04 |
2023-08-12 |
Not clear |
| M Inase, B M Li, J Tanj. Dopaminergic modulation of neuronal activity in the monkey putamen through D1 and D2 receptors during a delayed Go/Nogo task. Experimental brain research. vol 117. issue 2. 1998-02-04. PMID:9419068. |
these results suggest that dopamine can modulate the activity of single putaminal neurons through both d1 and d2 receptors and that the dopaminergic modulation through the two receptors in the putamen affects similar types of signals in behavioral control. |
1998-02-04 |
2023-08-12 |
monkey |
| T A Samad, W Krezel, P Chambon, E Borrell. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proceedings of the National Academy of Sciences of the United States of America. vol 94. issue 26. 1998-02-02. PMID:9405615. |
among them, dopamine d2 receptor is highly expressed in the striatum and the pituitary gland as well as by mesencephalic dopaminergic neurons. |
1998-02-02 |
2023-08-12 |
mouse |
| W Blenau, J Erber, A Bauman. Characterization of a dopamine D1 receptor from Apis mellifera: cloning, functional expression, pharmacology, and mRNA localization in the brain. Journal of neurochemistry. vol 70. issue 1. 1998-02-02. PMID:9422342. |
dopaminergic receptor ligands compete for this high-affinity binding, with the following order of potency: r(+)-lisuride > chlorpromazine = cis(z)-flupentixol > dopamine > s(+)-butaclamol > r(+)-sch 23390 > haloperidol. |
1998-02-02 |
2023-08-12 |
Not clear |
| A D Crocke. The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra. Reviews in the neurosciences. vol 8. issue 1. 1998-01-30. PMID:9402645. |
the importance of the nigrostriatal dopaminergic pathway in motor control is widely accepted and it is generally believed that the motor symptoms of parkinson's disease result solely from reduced release of dopamine from terminals in the striatum. |
1998-01-30 |
2023-08-12 |
Not clear |
| Q Wei, O P Jurma, J K Anderse. Increased expression of monoamine oxidase-B results in enhanced neurite degeneration in methamphetamine-treated PC12 cells. Journal of neuroscience research. vol 50. issue 4. 1998-01-29. PMID:9404723. |
in vivo administration of methamphetamine (ma) produces selective damage to dopaminergic nerve terminals, which is hypothesized to be due to release of dopamine from synaptic vesicles within the terminals, allowing the generation of reactive oxygen species (ros) via dopamine metabolism. |
1998-01-29 |
2023-08-12 |
Not clear |
| Q Wei, O P Jurma, J K Anderse. Increased expression of monoamine oxidase-B results in enhanced neurite degeneration in methamphetamine-treated PC12 cells. Journal of neuroscience research. vol 50. issue 4. 1998-01-29. PMID:9404723. |
these data suggest that dopamine metabolism and subsequent ros production may be key elements in ma-induced neurite degeneration in dopaminergic neurons. |
1998-01-29 |
2023-08-12 |
Not clear |
| A Hoffman, M Afargan, J Backon, I Perlstei. The anticonvulsant effect of deprenyl on pentylenetetrazol-induced seizures in Lewis rats. The International journal of neuroscience. vol 90. issue 3-4. 1998-01-26. PMID:9352429. |
the data suggests that the mechanism of this effect is not associated with the dopaminergic activity of deprenyl since pretreatment with both bromocriptine (a dopamine d2 agonist) and haloperidol (dopamine antagonist) did not affect the seizure threshold, whereas levodopa caused a proconvulsant effect. |
1998-01-26 |
2023-08-12 |
rat |
| D Marona-Lewicka, D E Nichol. 5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat. Neuropharmacology. vol 36. issue 10. 1998-01-22. PMID:9423936. |
the results suggest that the enhanced behavioral response to amphetamine may be due either to an increased sensitivity of dopaminergic neurons in the mesolimbic area, or to an enhanced release of dopamine by amphetamine. |
1998-01-22 |
2023-08-12 |
rat |